You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Headache
 •Alert me on articles by topic

Pituitary Volume and Headache

Size Is Not Everything

Miles J. Levy; H. Rolf Jäger, MD; Michael Powell, FRCS; Manjit S. Matharu, MRCP; Karim Meeran, MD; Peter J. Goadsby, MD, PhD, DSc, FRACP, FRCP

Arch Neurol. 2004;61:721-725.

Background  Pituitary tumors are commonly associated with disabling headache. The accepted mechanisms for headache are dural stretch and cavernous sinus invasion.

Objective  To determine if there is a relationship between pituitary tumor size and the report of headache.

Design  We prospectively studied 63 patients who were initially seen with pituitary tumors. Clinical headache scores, pituitary tumor volume, and the extent of cavernous sinus invasion were obtained for each patient.

Results  The prevalence of headache was 70%. There was no positive correlation the between clinical headache score and pituitary volume (r = –0.32, P = .01, Spearman rank correlation). There was also no association between cavernous sinus invasion and headache. There was a strong association between pituitary-associated headache and a family history of headache ({chi}2 = 8.36, P = .004).

Conclusions  These data suggest that a pituitary tumor–associated headache may not simply be a structural problem. Other factors such as family history of headache, and the endocrine activity of the tumor may be equally important determinants of headache. Elucidating these mechanisms will aid in the treatment of these patients and further our understanding of other headache syndromes.


From the Headache Group (Mr Levy and Drs Matharu and Goadsby) and the Department of Radiology (Dr Jäger), Institute of Neurology, Department of Neurosurgery, National Hospital for Neurology and Neurosurgery (Dr Powell), and the Department of Endocrinology, Hammersmith and Charing Cross Hospitals Trust (Dr Meeran), London, England.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Paroxysmal hemicrania: a prospective clinical study of 31 cases
Cittadini et al.
Brain 2008;131:1142-1155.
ABSTRACT | FULL TEXT  

Acromegaly
Goadsby et al.
NEJM 2007;356:1274-1276.
FULL TEXT  

Autoimmune Hypophysitis
Caturegli et al.
Endocr. Rev. 2005;26:599-614.
ABSTRACT | FULL TEXT  

The clinical characteristics of headache in patients with pituitary tumours
Levy et al.
Brain 2005;128:1921-1930.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.